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Abstract: The present study was designed to investigate the question of whether or not 
astaxanthin improves stem cell potency via an increase in proliferation of neural progenitor 
cells (NPCs). Treatment with astaxanthin significantly increased proliferation and colony 
formation of NPCs. For identification of possible activated signaling molecules involved in 
active cell proliferation occurring after astaxanthin treatment, total protein levels of several 
proliferation-related  proteins,  and  expression  levels  of  proliferation-related  transcription 
factors, were assessed in NPCs. In Western blot analysis, astaxanthin induced significant 
activation  of  phosphatidylinositol  3-kinase  (PI3K)  and  its  downstream  mediators  in 
a time-dependent  manner.  Results  of  RT-PCR  analysis  showed  upregulation  of 
proliferation-related transcription factors and stemness genes. To estimate the relevance of 
PI3K and mitogen-activated protein, or extracellular signal-regulated kinase kinase (MEK) 
signaling  pathways  in  cell  growth  of  astaxanthin-treated  NPCs,  inhibition  assays  were 
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performed with LY294002, a specific inhibitor of PI3K, and PD98059, a specific inhibitor 
of MEK, respectively. These results clearly showed that astaxanthin induces proliferation 
of NPCs via activation of the PI3K and MEK signaling pathways and improves stem cell 
potency via stemness acting signals. 
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1. Introduction  
A stem cell is a special kind of cell, with a unique capacity to renew itself, to give rise to specialized 
cell types and for migration, proliferation, and cell survival [1]. Although most cells of the body, such 
as heart cells or skin cells, are committed to conduct specific functions, a stem cell is uncommitted and 
remains  uncommitted  until  it  receives  a  signal  to  develop  into  a  specialized  cell.  Its  proliferative 
capacity, combined with the ability to obtain active self renewal and to become specialized, ensures 
stem cells’ unique survival [1]. Neural progenitor cells (NPCs) have evoked great interest, given their 
expected capacity for self renewal resulting in expansion of the cell population. They also
 differentiate 
into desired cell types, thus representing
 new sources for cell replacement therapy [2,3]. To orchestrate 
self renewal via an increase in proliferation of NPCs, multiple signaling networks are activated by 
various  intracellular  and  extracellular  factors.  Here,  we  illustrate  the  role  of  astaxanthin  as  an 
extracellular factor that induces improvement of self renewal via increased proliferation of NPCs. 
Astaxanthin is widely distributed in nature, and is the principal pigment in crustaceans, salmonoids, 
and many other organisms [4–6]. It provides attractive pigmentation to many farm animals and also 
contributes to consumer appeal in the marketplace. In aquaculture, it is employed as a source of natural 
pigmentation and as a dietary supplement for trout and salmon [7,8]. This compound has important 
metabolic functions in animals, including neuroprotective actions [9–13], enhancement of immune 
response [14,15], and protection against diseases such as cancer [16,17] and antral ulcer [18,19] by 
scavenging  of  oxygen  radicals.  Antioxidant  activity  of  astaxanthin  has  been  reported  to  be 
approximately 10 times stronger than that of other carotenoids tested, including zeaxanthin, lutein, 
canthaxanthin, and -carotene, and 100 times greater than that of -tocopherol [20,21]. These effects 
are considered to be defense mechanisms against attack by reactive oxygen species. Astaxanthin also 
shows  a  strong  activity  as  an  inhibitor  of  oxygen  radical-mediated  lipid  peroxidation  [22,23]  
and  inhibits  hydrogen  peroxide  (H2O2)-mediated  apoptotic  cell  death  [24].  Therefore,  astaxanthin  
has  attracted  commercial  interest,  not  only  as  a  pigmentation  source,  but  also  as  a  potent 
antioxidative reagent. 
In the present study, we hypothesized that astaxanthin can improve stem cell potency via an increase 
in the proliferation potential of NPCs. To estimate this hypothesis, this study explored the ability of 
astaxanthin and signaling mechanisms that increase proliferation of NPCs. Int. J. Mol. Sci. 2010, 11                       
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2. Results and Discussion  
2.1.  Astaxanthin  Induces  Active  Cell  Proliferation  and  Improves  Stem  Cell  Potency  in  NPCs  via 
Stemness Acting Signals 
To confirm the effect of astaxanthin on cell growth, proliferation of NPCs treated with different 
concentrations  (1,  5,  and  10  ng/mL)  of  astaxanthin  for  three  days  was  evaluated  by  trypan  blue 
exclusion. As shown in Figure 1A, this treatment significantly increased proliferation of NPCs in a 
dose-dependent and time-dependent manner. In particular, 10 ng/mL astaxanthin showed the highest 
proliferation of NPCs. Therefore, 10 ng/mL was determined to be the optimal treatment for the study 
of  NPCs.  A  clonogenic  assay  was  also  performed  to  estimate  the  proliferation  efficiency  of 
astaxanthin-treated NPCs. Because colony-forming units (CFU) are single cell populations, increases 
in  CFU  values  show  that  astaxanthin  can  actively  stimulate  proliferation  of  NPCs.  Proliferation 
efficiency of CFU in astaxanthin-treated cells was assessed via visual colony counts. In the CFU assay, 
astaxanthin-treated  NPCs  showed  increased  colony  formation  compared  with  control  NPCs 
(Figure 1B).  In  particular,  10  ng/mL  astaxanthin-treated  NPCs  showed  an  approximately  two-fold 
increase in colony formation (Figure 1B). 
Figure  1. Astaxanthin stimulates cell proliferation of NPCs. (A) Proliferation of NPCs 
treated with different concentrations of astaxanthin (ASX) for 3 days were assessed by 
trypan  blue  exclusion.  Application  of  astaxanthin  for  3  days  significantly  increased 
proliferation of NPCs in a dose-dependent and time-dependent manner. Data were analyzed 
using analysis of variance with the Fisher test or t-test (* P < 0.05, ** P < 0.01); (B) A 
clonogenic (CFU) assay was performed to estimate proliferation efficiency of astaxanthin-
treated  NPCs.  In  the  CFU  assay,  10  ng/mL  astaxanthin-treated  NPCs  showed  an 
approximately 2-fold increase in colony formation compared with control NPCs. Data were 
analyzed using analysis of variance with the Fisher test or t-test (* P < 0.05, ** P < 0.01). 
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In  both  control NPCs  and astaxanthin-treated cells,  expression of molecular markers, including 
proliferation-related transcription factors and stemness genes, was assessed via RT-PCR. As shown in 
Figure  2A,  10  ng/mL  astaxanthin  applied  for  three  days  significantly  induced  upregulation  of 
proliferation-related transcription factors (Rex1, CDK1, and CDK2), coupled with overexpression of 
stemness  genes  (OCT4,  SOX2,  Nanog,  and  KLF4)  [25,26].  In  particular,  Rex1  expression  was 
markedly increased in astaxanthin-treated cells. This result revealed that Rex1 expression is closely 
associated with proliferation of NPCs. In a recent study, we showed that Rex1 is a major gene, the 
expression of which is closely associated with proliferation of adipose tissue stromal cells [27]. Our 
present results are consistent with a recent report in which enhancement of Rex1 expression caused 
increased efficiency of cell proliferation. According to a recent report, four transcription factors (Oct4, 
Sox2, Klf4, and c-Myc) have been shown to reprogram primary mouse fibroblasts in culture [28]. Also, 
a balance between Klf4 and c-Myc is, in all likelihood, necessary for stable reprogramming in induced 
pluripotent stem cells [28]. In this study, astaxanthin-treated NPCs were shown to overexpress not only 
Oct4, Sox2, Nanog, and Rex1, but also Klf4 for the acquisition of active self-renewal activity (Figure 
2A).  Therefore,  these  results  show  that astaxanthin can induce active cell proliferation and that it 
improves stem cell potency in NPCs via stemness acting signals. 
Figure 2. Astaxanthin induces active expression of several functional genes and stemness 
genes,  and  proliferation-related  signal  proteins  in  NPCs.  (A)  Astaxanthin  induced 
upregulation  of  proliferation-related  transcription  factors  (Rex1,  CDK1,  and  CDK2), 
coupled  with  overexpression  of  stemness  genes  (OCT4,  SOX2,  Nanog,  and  KLF4);  
(B)  Astaxanthin  induced  significant  activation  of  PI3K  and  its  downstream  mediators,  
p-Rac, p-c-Raf, p-MEK, p-ERK, p-Akt, p-mTOR, and p-Stat3 in a time-dependent manner.  
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2.2. Astaxanthin Induces Proliferation of NPCs via PI3K and MEK Signaling Pathways 
For  identification of possible  activated  signaling  molecules  involved in active cell  proliferation 
occurring after astaxanthin treatment, total protein levels of several proliferation-related proteins were 
assessed in NPCs by Western blot analysis. Figure 2B shows the results of Western blot in astaxanthin-
treated  NPCs  for  different lengths  of  time  (0, 6, and 12 h). In Western  blot analysis, astaxanthin 
induced  significant  activation  of  PI3K  and  its  downstream  mediators,  p-Rac,  p-c-Raf,  
p-MEK,  p-ERK,  p-Akt,  p-mTOR,  and  p-Stat3  [29]  in  a  time-dependent  manner.  This  study  then 
examined the relevance of the PI3K and MEK signaling pathways in cell growth in astaxanthin-treated 
NPCs.  For  these  studies,  inhibition  assays  were  performed  with  specific  inhibitors,  LY294002  (a 
specific inhibitor of PI3K) and PD98059 (a specific inhibitor of MEK). Astaxanthin-treated NPCs were 
treated with LY294002 or PD98059, or were left untreated. After LY294002 and PD98059 treatment 
respectively, the relative cell proliferation rate of astaxanthin-treated NPCs was assessed by trypan blue 
exclusion:  Results are  shown in  Figure 3A. PI3K and MEK  inhibition
 have  been shown to cause 
inhibition of cell growth in astaxanthin-treated NPCs in vitro. As shown in Figure 3B, the results of 
Western  blot  analysis  indicated  that  LY294002  significantly  induced  downregulation  of  PI3K,  
p-Rac, p-c-Raf, p-MEK, p-ERK, p-Akt, p-mTOR, and p-Stat3 proteins.  
Figure  3. Astaxanthin induces proliferation of NPCs via the PI3K and MEK signaling 
pathways. To estimate the  relevance  of the PI3K and MEK signaling pathways in cell 
growth  in  astaxanthin-treated  NPCs,  inhibition  assays  were  performed  with  LY294002 
(10 M) and PD98059 (10 M). (A) Inhibition of PI3K and MEK has been shown to cause 
inhibition  of  cell  growth  in  astaxanthin-treated  NPCs  in  vitro;  (B)  LY294002  induced 
downregulation of PI3K, p-Rac, p-c-Raf, p-MEK, p-ERK, p-Akt, p-mTOR, and p-Stat3 
proteins; (C) PD98059 significantly induced reduction of p-MEK, p-ERK, and p-Stat3;  
(D)  PD98059  caused  downregulation  of  proliferation-related  transcription  factors  and 
stemness genes.  
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Figure 3. Cont. 
 
In  addition,  PD98059  significantly  induced  reduction  of  p-MEK,  p-ERK,  and  p-Stat3  proteins 
(Figure  3C).  Results  of  RT-PCR  also  indicated  that  PD98059  caused  downregulation  of 
proliferation-related  transcription  factors  (Rex1,  CDK1,  and  CDK2)  and  stemness  genes  (OCT4, 
SOX2, Nanog, and KLF4) (Figure 3D). In this study, the activation of p-ERK in the astaxanthin-treated 
NPCs  resulted  in  the  induction  of  stemness  transcription  factor  expression,  particularly  Rex1 
expression (Figure 3). Conversely, inhibition of PI3K and MEK in NPCs induced a reduction in cell 
proliferation  (Figure  3A)  and  stemness  transcription  factor  expression  (Figure  3D).  Therefore,  the 
upregulation of Rex1 production by astaxanthin is clearly required for cell proliferation. This result 
indicated that Rex1 is a major gene, the expression of which is closely associated with the proliferation 
of NPCs, and that astaxanthin increases NPCs proliferation efficiency via an enhancement of Rex1 
expression. In conclusion, these results clearly showed that astaxanthin induces proliferation of NPCs 
via activation of the PI3K and MEK signaling pathways. 
Based  on  our  present  data,  we  suggest  a  model,  shown  in  Figure  4,  for  explanation  of  the 
astaxanthin-induced  cell  proliferation  mechanism  through  activation  of  the  PI3K  and  MEK 
signaling pathways. 
3. Experimental Section  
3.1. Astaxanthin Reagent  
Astaxanthin  (3,3’-dihydroxy-,-carotene-4,4’-dione)  was  purchased  from  Sigma  Chemicals 
(St. Louis, MO, U.S.) and used in all of the cell culture experiments. A stock solution of astaxanthin 
was made with dimethyl sulfoxide (DMSO) and stored at 4 ° C. The stock solution was diluted to 
working concentrations prior to use. 
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Figure  4.  Putative  cell  proliferation  mechanism  induced  by  astaxanthin  treatment. 
Astaxanthin  induces  proliferation  of  NPCs  via  activation  of  the  PI3K  and  MEK 
signaling pathways. 
Astaxanthin
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LY294002 PI3K
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p-MEK1/2
p-ERK1/2
p-Akt
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3.2. Mouse Neural Progenitor Cells (NPCs) Culture  
For preparation of NPCs, mice were anesthetized deeply using a pentobarbital in 0.9% sterile saline 
solution and sacrificed by decapitation. To obtain NPCs, the region of complete cervical enlargement 
(spinal  cord  level  C3  through  T1)  was  dissected  out.  The  tissue  was  minced,  washed  in  sterile 
Dulbecco’s phosphate buffered saline (DPBS), and digested in a solution of 0.125% of trypsin, DNase 
(0.01%, Sigma) in Hank’s balanced salt solution (HBSS) for 30 min at 37 ° C. Cells were transferred to 
culture dishes containing serum free growth medium, which consists of neurobasal (NB) medium with 
B27  supplement,  basic  fibroblast  growth  factor  (bFGF,  20  ng/mL),  and  epidermal  growth  factor  
(EGF, 20 ng/mL). 
3.3. Selenium Treatment in NPCs and Analysis of Cell Viability 
Cultured NPCs were seeded in 10 cm dishes at a density of 5 ×  10
5 and cultured in NB media at 
37 ° C in a CO2 incubator. Cells were then treated with astaxanthin at various concentrations (1, 5, and 
10 ng/mL) for 3 days. Cell viability was assessed by visual cell counts in conjunction with trypan blue 
exclusion. In all viability assays, triplicate wells were used for each condition, and each experiment 
was repeated at least three times. 
3.4. Colony-Forming Cell (CFU) Assay  
Proliferation efficiency of colony-forming units (CFU) in astaxanthin-treated cells was assessed. 
Cultured NPCs were seeded in 10 cm dishes at a density of 5 ×  10
5 and cultured in NB media at 37 ° C Int. J. Mol. Sci. 2010, 11                       
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in a CO2 incubator. Cells were then treated with astaxanthin (10 ng/mL) for 3 days. For the CFU assay, 
control NPCs and astaxanthin-treated NPCs were seeded in 10-cm dishes at a density of 2 ×  10
2 and 
cultured  in  NB  media  at  37 ° C  in  a  CO2  incubator.  After  15  days,  cells  were  fixed  with  4% 
paraformaldehyde (PFA) for 30 min at room temperature and stained with 0.1% toluidine blue in 1% 
PFA. Proliferation efficiency of the CFU was assessed via visual colony counts [30]. 
3.5. Western Blot Analysis  
For  confirmation  of  differentially  expressed  proteins  after  astaxanthin  (10  ng/mL)  treatment  in 
cultured  NPCs,  NPCs  and  astaxanthin-treated  cells  were lysed  in 500  μL of lysis  buffer (20  mM 
Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 
1 mM EGTA, 1 mM glycerophosphate, 1 mM Na3VO4, and 1 mM PMSF. Lysates were clarified by 
centrifugation at 15,000 ×  g for 10 min, and the total protein content was determined using a Bio-Rad 
(Millan, Italy) protein assay kit. For Western blotting, equal amounts (40 μg) of protein extracts in a 
lysis  buffer  were  subjected  to  10%  SDS-PAGE  analysis  and  transferred  to  a  nitrocellulose 
membrane [31]; anti-phosphatidylinositol 3-kinase (PI3K; 1:1000), anti-p-Rac (1:1000), anti-p-c-Raf 
(1:1000),  anti-p-mitogen-activated  protein  or  extracellular  signal-regulated  kinase  kinase  (MEK; 
1:1000), anti-p-extracellular signal-regulated kinase (ERK; 1:1000), anti-p-Stat3 (1:1000), anti-p-Akt 
(1:1000), p-mTOR (Cell Signaling Technology, Danvers, MA, U.S.; 1:1000), and anti-β-Actin (Sigma) 
antibodies  were  then  incubated  with  membranes.  Relative  band  intensities  were  determined  using 
Quality-one 1-D analysis software (Bio-Rad). 
3.6. Reverse Transcription-Polymerase Chain Reaction (RT-PCR)  
Total  cellular  RNA  was  extracted  with  Trizol  (Life  Technologies,  Frederick,  MD,  U.S.). 
Concentration of RNA was determined spectrophotometrically, and concentration and integrity were 
further  evaluated  by  agarose  gel  electrophoresis.  Residual  DNA,  if  any,  was  eliminated  from  the 
samples using DNase I (RNase-free, Takara Bio Inc, Kyoto, Japan). cDNA was synthesized from the 
RNA using an oligo-dT primer amplified by 35 cycles (94 ° C, 1 min; 55 ° C, 1 min; 72 ° C, 1 min) of 
PCR  using  20  pM  of  specific  primers.  PCR  amplification  was  performed  using  the  primer  sets. 
Duplicate  PCR  reactions  were  amplified  using  primer  designed  glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) as a control for assessment of PCR efficiency and for subsequent analysis by 
1.5% agarose gel electrophoresis. PCR products were stained with ethidium bromide [32]. 
3.7. Inhibition Assays 
To confirm the relevance of the PI3K and MEK signaling pathways in controlling the growth of 
astaxanthin-treated NPCs, cells were seeded in 10 cm dishes at a density of 5 ×  10
5 and cultured in NB 
media at 37 ° C in a CO2 incubator. Cells were then treated with astaxanthin (10 ng/mL) for 1 day. 
Astaxanthin-treated NPCs were treated with PI3K inhibitor LY294002 (10 M; Promega, Madison, 
WI, U.S.), MEK inhibitor PD98059 (10 M; Sigma), or were left untreated. Cells were analyzed by 
Western blot and RT-PCR [27]. 
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3.8. Statistical Analysis 
All data were presented as mean ±  S.E.M from five or more independent experiments. Statistical 
significance of the differences between groups was calculated by using the Student’s two tailed t-test. 
4. Conclusions  
In the present study, astaxanthin significantly increased proliferation of NPCs in a dose-dependent 
and time-dependent manner. Also astaxanthin markedly induced upregulation of proliferation-related 
transcription  factors  (Rex1,  CDK1,  and  CDK2),  coupled  with  overexpression  of  stemness  genes 
(OCT4, SOX2, Nanog, and KLF4) for the acquisition of active self-renewal activity. In particular, 
astaxanthin increased NPCs proliferation efficiency via an enhancement of Rex1 expression. Results of 
the CFU assay clearly indicated that astaxanthin can actively improve proliferation of NPCs, which 
was  associated  with  significant  activation  of  PI3K  and  its  downstream  mediators, p-Rac,  p-c-Raf, 
p-MEK, p-ERK, p-Akt, p-mTOR, and p-Stat3 in a time-dependent manner. Results from inhibition 
assays clearly showed that astaxanthin effectively induces proliferation of NPCs via activation of the 
PI3K and MEK signaling pathways. In conclusion, our data indicated that astaxanthin can improve 
stem cell potency via increased proliferation of NPCs. 
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